☰

Eliezer M. Van Allen

Affiliations: 
Dana Farber Cancer Institute, Harvard Medical School 
Area:
Cancer genomics
Google:
"Eliezer Van Allen"
Mean distance: (not calculated yet)
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Levi A. Garraway grad student (Cell Biology Tree)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
Myles Brown collaborator (Cell Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ricker CA, Meli K, Van Allen EM. (2024) Historical perspective and future directions: computational science in immuno-oncology. Journal For Immunotherapy of Cancer. 12
Kamran SC, Zhou Y, Otani K, et al. (2023) Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Hoffman SE, Dowrey TW, Villacorta Martin C, et al. (2023) Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. Science Advances. 9: eadd9668
Doe-Tetteh SA, Camp SY, Reales D, et al. (2023) Overcoming barriers to tumor genomic profiling through direct-to-patient outreach. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Crowdis J, Balch S, Sterlin L, et al. (2022) A patient-driven clinicogenomic partnership for metastatic prostate cancer. Cell Genomics. 2
Zhou M, Ko M, Hoge AC, et al. (2022) Patterns of structural variation define prostate cancer across disease states. Jci Insight
Barroso-Sousa R, Forman J, Collier K, et al. (2022) Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit. Jco Precision Oncology. 6: e2100413
Church AJ, Corson LB, Kao PC, et al. (2022) Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nature Medicine
Ricciuti B, Wang X, Alessi JV, et al. (2022) Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Jama Oncology
Hwang JH, Arafeh R, Seo JH, et al. (2022) CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor targeting therapies. Elife. 11
See more...